While alternative strategies that can achieve baseline hemostasis in patients with hemophilia A have recently been developed that largely eliminate the need for continual FVIII replacement [15,16,17], bleeding episodes are still most effectively treated with FVIII [37,38,39]. Here, F8 is linked to hemophilia A.